Christof Scheid

10.8k total citations
149 papers, 2.2k citations indexed

About

Christof Scheid is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Christof Scheid has authored 149 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Hematology, 65 papers in Oncology and 35 papers in Molecular Biology. Recurrent topics in Christof Scheid's work include Multiple Myeloma Research and Treatments (49 papers), Hematopoietic Stem Cell Transplantation (37 papers) and Protein Degradation and Inhibitors (23 papers). Christof Scheid is often cited by papers focused on Multiple Myeloma Research and Treatments (49 papers), Hematopoietic Stem Cell Transplantation (37 papers) and Protein Degradation and Inhibitors (23 papers). Christof Scheid collaborates with scholars based in Germany, United States and United Kingdom. Christof Scheid's co-authors include Udo Holtick, Michael Hallek, Sebastian Theurich, Michael von Bergwelt‐Baildon, Jens Chemnitz, Alexander Shimabukuro‐Vornhagen, Nicole Skoetz, Jens M. Chemnitz, Peter L. Stern and D. Söhngen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Christof Scheid

139 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christof Scheid Germany 28 1.1k 648 578 472 340 149 2.2k
Jianmin Wang China 26 1.3k 1.2× 700 1.1× 820 1.4× 415 0.9× 429 1.3× 141 2.7k
U. W. Schaefer Germany 26 976 0.9× 570 0.9× 375 0.6× 498 1.1× 232 0.7× 91 2.4k
Freda Passam Australia 31 991 0.9× 592 0.9× 780 1.3× 658 1.4× 244 0.7× 97 3.2k
Daniela Damiani Italy 31 1.2k 1.1× 1.1k 1.7× 843 1.5× 451 1.0× 565 1.7× 134 3.0k
Heinz Sill Austria 32 1.2k 1.1× 912 1.4× 1.2k 2.0× 271 0.6× 568 1.7× 137 3.3k
Leona Holmberg United States 24 1.0k 1.0× 809 1.2× 654 1.1× 411 0.9× 361 1.1× 99 2.2k
E. Thiel Germany 28 625 0.6× 646 1.0× 698 1.2× 425 0.9× 352 1.0× 121 2.5k
Seah H. Lim United States 29 960 0.9× 798 1.2× 1.2k 2.0× 1.4k 2.9× 381 1.1× 131 2.9k
Yoshiyuki Kosaka Japan 26 1.3k 1.2× 514 0.8× 792 1.4× 476 1.0× 261 0.8× 146 2.6k
Eva M. Weissinger Germany 31 985 0.9× 623 1.0× 1.1k 1.9× 792 1.7× 333 1.0× 86 3.6k

Countries citing papers authored by Christof Scheid

Since Specialization
Citations

This map shows the geographic impact of Christof Scheid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christof Scheid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christof Scheid more than expected).

Fields of papers citing papers by Christof Scheid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christof Scheid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christof Scheid. The network helps show where Christof Scheid may publish in the future.

Co-authorship network of co-authors of Christof Scheid

This figure shows the co-authorship network connecting the top 25 collaborators of Christof Scheid. A scholar is included among the top collaborators of Christof Scheid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christof Scheid. Christof Scheid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bethe, Ullrich, Peter Borchmann, Veronica Di Cristanziano, et al.. (2025). Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study. JMIR Research Protocols. 14. e60675–e60675.
2.
Kobbe, Guido, Tobias A.W. Holderried, Martina Crysandt, et al.. (2025). Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis. Blood Advances. 9(6). 1370–1375. 2 indexed citations
3.
Holtick, Udo, Hyatt Balke‐Want, Sandra Sauer, et al.. (2025). Sequential BCMA CAR T-cell therapy in refractory multiple myeloma. Blood Advances. 9(18). 4624–4630.
4.
Albrecht, Melanie, et al.. (2024). Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database of Systematic Reviews. 2024(11). CD010189–CD010189. 1 indexed citations
5.
Langer, P., Lukas John, Ina Monsef, et al.. (2024). Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant. Cochrane Database of Systematic Reviews. 2024(5). CD013595–CD013595. 8 indexed citations
6.
Onida, Francesco, Nico Gagelmann, Yves Chalandon, et al.. (2024). Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee. Blood. 143(22). 2227–2244. 8 indexed citations
7.
Kutsch, Nadine, Philipp Gödel, Conrad‐Amadeus Voltin, et al.. (2024). Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation. European Journal Of Haematology. 112(6). 984–987. 1 indexed citations
8.
Tresckow, Bastian von, Hans Christian Reinhardt, Christian Jehn, et al.. (2024). How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective. Frontiers in Oncology. 14. 1466803–1466803. 1 indexed citations
9.
Scheid, Christof. (2024). Molecular monitoring of MDS: Watch this space!. British Journal of Haematology. 205(3). 757–758. 1 indexed citations
10.
Sidana, Surbhi, Christof Scheid, Petra Schuberth, et al.. (2024). Global Manufacturing Experience with Idecabtagene Vicleucel in Patients with Relapsed and Refractory Multiple Myeloma. Blood. 144(Supplement 1). 3476–3476.
11.
Gehlsen, Uta, Michael E. Stern, Jeremy Franklin, et al.. (2022). Desiccating Stress Significantly Increases the Risk for Chronic Ocular Graft-versus-Host-Disease. Transplantation and Cellular Therapy. 28(11). 782.e1–782.e7. 6 indexed citations
12.
Kaddu‐Mulindwa, Dominic, Philipp Gödel, Nadine Kutsch, et al.. (2022). Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(7). e498–e506. 1 indexed citations
13.
Stern, Anat, Carolyn D. Alonso, Carolina García‐Vidal, et al.. (2021). Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study. Journal of Antimicrobial Chemotherapy. 76(11). 3020–3028. 12 indexed citations
14.
Seckinger, Anja, Michael Heider, Martina Rudelius, et al.. (2021). MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma. Blood Advances. 6(2). 515–520. 7 indexed citations
15.
Stegelmann, Frank, Martin Grießhammer, Markus Bangerter, et al.. (2017). COMBINATION THERAPY OF POMALIDOMIDE PLUS RUXOLITINIB IN MYELOFIBROSIS: RESULTS FROM COHORT 1 OF THE MPNSG-0212 TRIAL (NCT01644110). Haematologica. 102. 280–280. 2 indexed citations
16.
Claßen, Tim, Christof Scheid, Stefan Landgraeber, & Markus Jäger. (2016). Besonderheiten beim elektiven Hüftgelenkersatz des älteren Menschen. Der Orthopäde. 46(1). 25–33. 6 indexed citations
17.
Shimabukuro‐Vornhagen, Alexander, Kerstin Wennhold, Andreas Draube, et al.. (2014). Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity. The Journal of Immunology. 193(10). 5294–5305. 29 indexed citations
18.
Scheid, Christof, Gisela Kremer, Michael Fuchs, et al.. (2004). Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy. Nutrition. 20(3). 249–254. 28 indexed citations
19.
Scheid, Christof, et al.. (1999). A case of thrombotic thrombocytopenic purpura in an adult treated with vincristine. Annals of Hematology. 78(1). 39–42. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianmin Wang Breakdown of academic impact, for papers by U. W. Schaefer Breakdown of academic impact, for papers by Freda Passam Breakdown of academic impact, for papers by Daniela Damiani Breakdown of academic impact, for papers by Heinz Sill Breakdown of academic impact, for papers by Leona Holmberg Breakdown of academic impact, for papers by E. Thiel Breakdown of academic impact, for papers by Seah H. Lim Breakdown of academic impact, for papers by Yoshiyuki Kosaka Breakdown of academic impact, for papers by Eva M. Weissinger
Rankless by CCL
2026